Effect of Dapagliflozin on Left Atrial Strain Parameters in Diabetic Patients with Paroxysmal Atrial Fibrillation | ||
| Suez Canal University Medical Journal | ||
| Article 3, Volume 28, Issue 1, January 2025, Pages 16-27 PDF (426.72 K) | ||
| Document Type: Original Article | ||
| DOI: 10.21608/scumj.2025.416334 | ||
| Authors | ||
| Fathy Nada* ; Mohammed El Merry; Ahmed Abdellah | ||
| Cardiology department, Faculty of Medicine, Suez Canal University, Ismailia, Egypt | ||
| Abstract | ||
| Background: Atrial fibrillation (AF) is a common arrythmia in diabetes mellitus (DM). Left atrial strain (LAS) and electromechanical delay (EMD) are important AF predictors. Aim: To investigate the effect of dapagliflozin added to the standard antidiabetic treatment on LAS and EMD in type 2 DM (T2DM) patients with paroxysmal AF. Subjects and Methods: Diabetic patients in sinus rhythm with history of paroxysmal AF diagnosed by Holter electrocardiogram (ECG) or hospitalization were assigned into 2 groups. Dapagliflozin group: dapagliflozin 10 mg added to the standard antidiabetic treatment. Control group: standard antidiabetic treatment without added Sodium-Glucose-Cotransporter inhibitors (SGLT2i). Both groups were on beta blockers to prevent AF recurrence. We assessed baseline characteristics, echocardiography, LAS, EMD, and paroxysmal AF prevalence in both groups. Results: Dapagliflozin group (113 patients) has a postive improvement in diastolic function (E/e’ reduced from 9.9±2.4 to 7.8±1.8, P< 0.01), LA reservoir strain (26.5±7.9% to 28.9±3.8%, P< 0.015), LA contraction strain (10.8±4.9% to 12.2±5.9%, P< 0.021), and interatrial EMD (29.75±7.53 to 21.72±4.51 milliseconds, P< 0.029) at 12-months follow-up. Likewise, paroxysmal AF has occurred in 7.1% of dapagliflozin group vs 13.8% in control group at 12-months follow-up, P value Conclusion: Dapagliflozin addition to the standard antidiabetic treatment was associated with reduction of LA strain and interatrial electromechanical delay in type 2 DM patients who have paroxysmal AF. Moreover, this was associated with reduction of paroxysmal AF recurrence as documented by Holter ECG or hospitalization. | ||
| Keywords | ||
| Dapagliflozin; Diabetes Mellitus; LA Strain; Paroxysmal AF; Interatrial EMD | ||
|
Statistics Article View: 78 PDF Download: 47 |
||
